Cargando…
Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients
BACKGROUND/AIMS: Several clinical factors have been used to predict the response for concurrent chemoradiotherapy (CCRT); however, these factors are insufficient for prognostic predictions. We investigated clinical factors to assess whether they could be used to predict the response to CCRT and the...
Autores principales: | Nam, Su Youn, Jeon, Seong Woo, Lee, Sang Jik, Kwon, Yong Hwan, Lee, Hyun Seok, Kim, Sung Kook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366147/ https://www.ncbi.nlm.nih.gov/pubmed/32000467 http://dx.doi.org/10.5009/gnl19165 |
Ejemplares similares
-
Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015) -
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017) -
Quality of information on the Internet for Korean patients with inflammatory bowel disease
por: Yoon, Jun Sik, et al.
Publicado: (2019) -
The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016) -
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)